Diamines & Chemicals Ltd

₹ 230 -4.83%

23 Oct - close price

About

Incorporated in 1976, Diamines and Chemicals Ltd is in the business of manufacturing and marketing of organic chemicals compounds^[1]

Key Points

Business Overview:^[1]
DCL is an ISO 9001:2015, ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018, and DSIR-certified sole manufacturer of ethylene amines in India. It also manufactures Piperazine Anhydrous and Piperazine Solutions.

Website BSE NSE

Market Cap ₹ 231 Cr.
Current Price ₹ 230
High / Low ₹ 308 / 208
Stock P/E
Book Value ₹ 157
Dividend Yield 0.00 %
ROCE -8.26 %
ROE -7.93 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -9.37% over past five years.
Company has a low return on equity of 1.21% over last 3 years.
Working capital days have increased from 174 days to 244 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	31.70	19.92	23.03	29.38	16.84	19.19	17.51	17.93	12.25	9.30	7.64	9.29	14.37
	22.11	14.93	18.31	26.00	18.20	15.58	15.99	16.24	16.20	13.19	10.50	12.40	13.99
Operating Profit	9.59	4.99	4.72	3.38	-1.36	3.61	1.52	1.69	-3.95	-3.89	-2.86	-3.11	0.38
OPM %	30.25%	25.05%	20.50%	11.50%	-8.08%	18.81%	8.68%	9.43%	-32.24%	-41.83%	-37.43%	-33.48%	2.64%
	0.70	0.61	0.58	0.66	0.66	0.81	0.77	0.93	1.89	0.61	0.53	0.92	0.51
Interest	0.04	0.04	0.13	-0.01	0.03	0.06	0.17	0.09	0.01	0.07	0.13	0.10	0.02
Depreciation	0.50	0.69	0.94	0.73	0.86	0.88	0.88	0.87	0.89	0.96	0.98	0.96	0.92
Profit before tax	9.75	4.87	4.23	3.32	-1.59	3.48	1.24	1.66	-2.96	-4.31	-3.44	-3.25	-0.05
Tax %	28.21%	23.61%	30.50%	33.43%	6.92%	27.30%	34.68%	20.48%	-7.43%	-5.57%	-3.20%	-25.85%	-0.00%
	7.01	3.41	2.80	2.25	-1.75	2.46	0.75	1.26	-2.81	-4.15	-3.40	-2.42	-0.10
EPS in Rs	7.17	3.49	2.86	2.30	-1.79	2.51	0.77	1.29	-2.87	-4.24	-3.48	-2.41	-0.10
Raw PDF

Upcoming result date: 28 October 2026

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	67	57	44	39	36	63	66	110	104	71	38	41
	57	50	38	34	31	37	44	55	81	66	52	50
Operating Profit	10	8	6	5	4	26	22	56	23	5	-14	-9
OPM %	15%	14%	13%	13%	13%	41%	33%	50%	22%	8%	-36%	-23%
	0	0	0	0	0	2	2	3	3	3	4	3
Interest	4	4	3	3	3	0	0	0	0	0	0	0
Depreciation	2	2	2	2	2	2	2	2	3	3	4	4
Profit before tax	5	2	0	-0	0	26	22	56	22	5	-14	-11
Tax %	29%	25%	9%	379%	-212%	19%	24%	26%	28%	38%	-10%
	4	1	0	-2	0	21	17	42	15	3	-13	-10
EPS in Rs	3.60	1.38	0.40	-1.63	0.26	21.46	17.08	42.83	15.81	2.79	-12.71	-10.23
Dividend Payout %	28%	4%	-0%	-0%	-0%	23%	18%	7%	16%	36%	-0%

Compounded Sales Growth
10 Years:	1%
5 Years:	-9%
3 Years:	-30%
TTM:	-39%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-707%

Stock Price CAGR
10 Years:	16%
5 Years:	-3%
3 Years:	-21%
1 Year:	-21%

Return on Equity
10 Years:	%
5 Years:	10%
3 Years:	1%
Last Year:	-8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	10	10	10	10	10	10	10	10	10
Reserves	24	24	25	23	23	75	90	125	138	151	147
	26	20	20	20	16	0	-0	-0	-0	0	8
	15	13	10	10	9	10	10	17	15	17	9
Total Liabilities	75	66	65	63	57	95	111	151	163	178	174
	35	33	32	29	27	22	38	40	65	64	65
CWIP	1	2	1	1	1	0	2	21	1	2	19
Investments	0	0	0	0	0	6	13	13	16	16	10
	39	32	32	32	28	66	58	76	81	96	80
Total Assets	75	66	65	63	57	95	111	151	163	178	174

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-1	16	3	2	7	15	27	16	22	-5	-11
	-4	-5	1	1	0	-15	-21	-9	-19	15	-29
	5	-11	-4	-3	-7	-4	-5	-6	-3	10	18
Net Cash Flow	-0	-0	-0	-0	-0	-3	0	2	-0	19	-22
Free Cash Flow	-5	11	2	2	7	4	15	-7	13	-9	-32
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	16%	212%	50%	54%	161%	85%	152%	56%	125%	-75%	73%

Ratios

Consolidated / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	56	66	67	73	76	55	55	76	59	71	52
Inventory Days	178	122	184	184	155	284	43	234	135	336	503
Days Payable	71	58	67	52	34	65	45	105	40	93	47
Cash Conversion Cycle	163	130	184	205	196	273	54	204	154	313	508
Working Capital Days	-1	-14	11	32	26	103	40	96	94	185	244
ROCE %		10%	7%	6%	6%		24%	48%	16%	3%	-8%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Export Turnover (FOB value)
INR Lakhs ・Standalone data

xxx.xx	xx.xx	xxx.xx	xx.xx	x.xx	xxx.xx	x,xxx.xx	x,xxx.xx	xxx.xx	xxx.xx	xxx.xx
x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
xx.xx	x.xx	xx.xx	xx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx
x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
xx	xx	xx	xx	xxx		xxx	xxx	xxx	xxx	xxx
x.xx	x.xx	x.xx		x.xx				x.xx		x.xx

Please log in to see hidden values.

Production Volume of Speciality Chemicals
MT ・Standalone data

R&D Expenditure
INR Lakhs ・Standalone data

Sales Volume of Manufactured Goods
MT ・Standalone data

Number of Permanent Employees
count ・Standalone data

R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

12 Recently

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	54.64%	54.87%	54.87%	54.87%	54.87%	55.17%	55.21%	55.21%	55.34%	57.41%	57.50%	57.57%
	0.00%	0.04%	0.00%	0.00%	0.00%	0.02%	0.00%	0.00%	0.00%	0.08%	0.00%	0.00%
	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	0.02%
	45.34%	45.07%	45.10%	45.11%	45.10%	44.77%	44.76%	44.77%	44.64%	42.51%	42.48%	42.42%
No. of Shareholders	16,094	15,481	15,175	14,478	14,001	13,794	13,645	13,363	13,154	12,731	12,633	12,563

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	65.20%	65.20%	65.20%	54.74%	54.23%	54.44%	54.64%	54.87%	55.17%	57.41%	57.57%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.11%	0.04%	0.02%	0.08%	0.00%
	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.03%	0.03%	0.03%	0.02%	0.02%
	0.00%	0.70%	0.70%	0.85%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	34.76%	34.06%	34.06%	44.38%	45.74%	45.52%	45.21%	45.07%	44.77%	42.51%	42.42%
No. of Shareholders	9,445	8,938	9,310	9,342	12,736	12,855	13,083	15,481	13,794	12,731	12,563

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Diamines & Chemicals Ltd

Diamines & Chemicals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings